Left Brain Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Left Brain Wealth Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,486	Closed	-$546K	–	75
2023 Q4	$546K	Hold	3,486	–	–	0.32%	59
2023 Q3	$543K	Hold	3,486	–	–	0.34%	59
2023 Q2	$577K	Sell	3,486 -171	-5%	-$27.6K	0.35%	57
2023 Q1	$599K	Sell	3,657 -1,202	-25%	-$194K	0.41%	54
2022 Q4	$858K	Buy	+4,859	New	+$839K	0.64%	38

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Left Brain Wealth Management's JNJ Position: Q1 2024 in Review

Left Brain Wealth Management sold out of Johnson & Johnson (JNJ) in Q1 2024, closing a stake of 3,486 shares — an estimated $546K sold.

Left Brain Wealth Management first reported a position in JNJ in Q4 2022 and held it in 5 quarters. The position peaked at $858K in Q4 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

Left Brain Wealth Management reported no remaining Johnson & Johnson position as of Q1 2024 after selling out during the quarter.
Left Brain Wealth Management sold 3,486 Johnson & Johnson shares in Q1 2024, an estimated $546K.
Left Brain Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 5 quarters.
Left Brain Wealth Management's Johnson & Johnson position peaked at $858K in Q4 2022.
3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Left Brain Wealth Management's 13F filing for Q1 2024, filed 9 May 2024.